Key facts
- PenMed’s last known valuation is $3.4M (Apr 2025).
- It has raised $940K; the latest was Later Stage VC ($450K) in Apr 2025.
- Notable investors include The FSE Group.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for PenMed
- ·The full record, as it builds
Funding rounds
No funding rounds for PenMed are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About PenMed
Developer of intelligent critical care medical devices and integrated healthcare technologies designed for anesthesia and respiratory incidents. The company's platform provides full-stack embedded system development, electronic design, mechanical engineering, and advanced software control systems for modular ventilators and anesthesia machines, enabling healthcare organizations to improve physiological outcomes through data-driven decision-making.
- Sector
- Healthcare
- HQ
- Totnes, United Kingdom
- Founded
- 2018
- Employees
- 8
- Website
- penmedtech.com/
- Ownership
- Privately Held (backing)
PenMed doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in PenMed shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on PenMed in its N-PORT filings yet. We sweep new filings monthly.